Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC is a research paper published in JTO Clinical and Research Reports (2021). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: EB\u20141K23ES029105-01A1
National Institutes of Health
Grant: KS\u2014K08L132055
National Institutes of Health
Grant: EB—1K23ES029105-01A1
National Institutes of Health
Grant: KS—K08L132055
National Institutes of Health
Grant: 1K23ES029105-01A1
Relationship Between Indoor Ultrafine Particle Exposure and Respiratory Morbidity, Inflammation, and Oxidative Stress in Children with Asthma
National Institutes of Health
Grant: 5K08HL132055-05
ROS-induced endothelial dysfunction in pulmonary arterial hypertension
American Society of Clinical Oncology
Celgene
Merck
Pfizer
Bristol-Myers Squibb
Genentech
Novartis
AbbVie
AstraZeneca
Eli Lilly and Company
FWCI
0.81
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals